WHO halts hydroxychloroquine, HIV drugs in COVID trials after failure to reduce death – Sight Magazine

The World Health Organization said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalised patients with COVID-19 after they failed to reduce mortality.